# Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

> **NCT07499440** · PHASE2 · NOT_YET_RECRUITING · sponsor: **HB BioTech, LLC** · enrollment: 200 (estimated)

## Conditions studied

- PTSD
- Mental Illness

## Interventions

- **DRUG:** HB-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07499440
- **Lead sponsor:** HB BioTech, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-09
- **Final completion:** 2027-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07499440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07499440, "Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07499440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*